Edwards Lifesciences | Fremdkapital



Loan Capital Veränderung Datum
Abbott USD 12.62B 200M 2024-12
AtriCure USD 69.15M 7.28M 2024-12
Baxter International USD 10.37B 63M 2024-12
Becton, Dickinson and Co. USD 17.44B 500M 2024-12
Boston Scientific USD 8.97B 265M 2024-12
Cooper Companies USD 2.49B 59.2M 2025-01
Dexcom USD 1.3B 1.2B 2024-12
Edwards Lifesciences USD 597.7M 200K 2024-12
Globus Medical USD 298K 411K 2024-12
Hologic USD 2.49B 19M 2024-12
ICU Medical USD 1.53B 11.39M 2024-12
Insulet USD 1.3B 60.2M 2024-12
Integra LifeSciences USD 1.2B 9.07M 2024-12
Intuitive Surgical USD 0 0 2024-12
J&J USD 30.65B 638M 2024-12
Masimo USD 727.9M 5.3M 2024-12
Medtronic USD 23.99B 622M 2025-01
Merit Medical Systems USD 729.55M 20.95M 2024-12
Stryker USD 12.19B 1.14B 2024-12
Tandem Diabetes Care USD 308.27M 437K 2024-12
Teleflex USD 1.56B 105.68M 2024-12
Zimmer Biomet Holdings USD 5.34B 603.9M 2024-12



Edwards Lifesciences Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.